Clinical Trial Update: Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of brimonidine intravitreal implant for geographic atrophy due to age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy Due to Age-related Macular Degeneration

Drugs mentioned

• Brimonidine intravitreal implant (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2013-04-26